APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atracurium Besylate Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Atracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchAtracurium Besylate Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Atracurium Besylate Injection Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Atracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atracurium Besylate Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Atracurium Besylate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Atracurium Besylate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Atracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Atracurium Besylate Injection include Qilu Pharma, Pfizer, Hengrui Medicine, GSK, SGPharma, Samarth Life Sciences, Lexicare Pharma, HBM Pharma and Gland Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Atracurium Besylate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Atracurium Besylate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atracurium Besylate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atracurium Besylate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Atracurium Besylate Injection Segment by Company

Qilu Pharma

Pfizer

Hengrui Medicine

GSK

SGPharma

Samarth Life Sciences

Lexicare Pharma

HBM Pharma

Gland Pharma

Flagship Biotech

Centurion Healthcare

American Remedies Healthcare

Atracurium Besylate Injection Segment by Type

2.5ml:12.5mg

5ml:25mg

Atracurium Besylate Injection Segment by Application

Surgery

Medical Examination

Atracurium Besylate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atracurium Besylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atracurium Besylate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atracurium Besylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Atracurium Besylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Atracurium Besylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Atracurium Besylate Injection Industry Trends Table 2. Atracurium Besylate Injection Industry Drivers Table 3. Atracurium Besylate Injection Industry Opportunities and Challenges Table 4. Atracurium Besylate Injection Industry Restraints Table 5. Global Atracurium Besylate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Atracurium Besylate Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Atracurium Besylate Injection Sales by Manufacturers (L) & (2021-2026) Table 8. Global Atracurium Besylate Injection Sales Market Share by Manufacturers Table 9. Global Atracurium Besylate Injection Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global Atracurium Besylate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Atracurium Besylate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Atracurium Besylate Injection Manufacturers, Product Type & Application Table 13. Global Atracurium Besylate Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Atracurium Besylate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2.5ml:12.5mg Table 17. Major Manufacturers of 5ml:25mg Table 18. Global Atracurium Besylate Injection Sales by Type 2021 VS 2025 VS 2032 (L) Table 19. Global Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 20. Global Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 21. Global Atracurium Besylate Injection Sales Market Share by Type (2021-2026) Table 22. Global Atracurium Besylate Injection Sales Market Share by Type (2027-2032) Table 23. Global Atracurium Besylate Injection Revenue by Type 2021 VS 2025 VS 2032 (L) Table 24. Global Atracurium Besylate Injection Revenue by Type (2021-2026) & (L) Table 25. Global Atracurium Besylate Injection Revenue by Type (2027-2032) & (L) Table 26. Global Atracurium Besylate Injection Revenue Market Share by Type (2021-2026) Table 27. Global Atracurium Besylate Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Surgery Table 29. Major Manufacturers of Medical Examination Table 30. Global Atracurium Besylate Injection Sales by Application 2021 VS 2025 VS 2032 (L) Table 31. Global Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 32. Global Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 33. Global Atracurium Besylate Injection Sales Market Share by Application (2021-2026) Table 34. Global Atracurium Besylate Injection Sales Market Share by Application (2027-2032) Table 35. Global Atracurium Besylate Injection Revenue by Application 2021 VS 2025 VS 2032 (L) Table 36. Global Atracurium Besylate Injection Revenue by Application (2021-2026) & (L) Table 37. Global Atracurium Besylate Injection Revenue by Application (2027-2032) & (L) Table 38. Global Atracurium Besylate Injection Revenue Market Share by Application (2021-2026) Table 39. Global Atracurium Besylate Injection Revenue Market Share by Application (2027-2032) Table 40. Global Atracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 41. Global Atracurium Besylate Injection Sales by Region (2021-2026) & (L) Table 42. Global Atracurium Besylate Injection Sales Market Share by Region (2021-2026) Table 43. Global Atracurium Besylate Injection Sales Forecasted by Region (2027-2032) & (L) Table 44. Global Atracurium Besylate Injection Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 46. North America Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 47. North America Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 48. Europe Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 49. Europe Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 50. Europe Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 51. Asia Pacific Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 52. Asia Pacific Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 53. Asia Pacific Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 54. South America, Middle East and Africa Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 55. South America, Middle East and Africa Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 56. South America, Middle East and Africa Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 57. Global Atracurium Besylate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Atracurium Besylate Injection Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Atracurium Besylate Injection Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Atracurium Besylate Injection Revenue Market Share by Region (2021-2026) Table 61. Global Atracurium Besylate Injection Revenue Market Share by Region (2027-2032) Table 62. Qilu Pharma Company Information Table 63. Qilu Pharma Business Overview Table 64. Qilu Pharma Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Qilu Pharma Atracurium Besylate Injection Product Portfolio Table 66. Qilu Pharma Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Pfizer Atracurium Besylate Injection Product Portfolio Table 71. Pfizer Recent Development Table 72. Hengrui Medicine Company Information Table 73. Hengrui Medicine Business Overview Table 74. Hengrui Medicine Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Hengrui Medicine Atracurium Besylate Injection Product Portfolio Table 76. Hengrui Medicine Recent Development Table 77. GSK Company Information Table 78. GSK Business Overview Table 79. GSK Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GSK Atracurium Besylate Injection Product Portfolio Table 81. GSK Recent Development Table 82. SGPharma Company Information Table 83. SGPharma Business Overview Table 84. SGPharma Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. SGPharma Atracurium Besylate Injection Product Portfolio Table 86. SGPharma Recent Development Table 87. Samarth Life Sciences Company Information Table 88. Samarth Life Sciences Business Overview Table 89. Samarth Life Sciences Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Samarth Life Sciences Atracurium Besylate Injection Product Portfolio Table 91. Samarth Life Sciences Recent Development Table 92. Lexicare Pharma Company Information Table 93. Lexicare Pharma Business Overview Table 94. Lexicare Pharma Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Lexicare Pharma Atracurium Besylate Injection Product Portfolio Table 96. Lexicare Pharma Recent Development Table 97. HBM Pharma Company Information Table 98. HBM Pharma Business Overview Table 99. HBM Pharma Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. HBM Pharma Atracurium Besylate Injection Product Portfolio Table 101. HBM Pharma Recent Development Table 102. Gland Pharma Company Information Table 103. Gland Pharma Business Overview Table 104. Gland Pharma Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Gland Pharma Atracurium Besylate Injection Product Portfolio Table 106. Gland Pharma Recent Development Table 107. Flagship Biotech Company Information Table 108. Flagship Biotech Business Overview Table 109. Flagship Biotech Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Flagship Biotech Atracurium Besylate Injection Product Portfolio Table 111. Flagship Biotech Recent Development Table 112. Centurion Healthcare Company Information Table 113. Centurion Healthcare Business Overview Table 114. Centurion Healthcare Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Centurion Healthcare Atracurium Besylate Injection Product Portfolio Table 116. Centurion Healthcare Recent Development Table 117. American Remedies Healthcare Company Information Table 118. American Remedies Healthcare Business Overview Table 119. American Remedies Healthcare Atracurium Besylate Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. American Remedies Healthcare Atracurium Besylate Injection Product Portfolio Table 121. American Remedies Healthcare Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Atracurium Besylate Injection Distributors List Table 125. Atracurium Besylate Injection Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Atracurium Besylate Injection Product Image Figure 2. Global Atracurium Besylate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atracurium Besylate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Atracurium Besylate Injection Sales (2021-2032) & (L) Figure 5. Global Atracurium Besylate Injection Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 Atracurium Besylate Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2.5ml:12.5mg Image Figure 9. 5ml:25mg Image Figure 10. Global Atracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 11. Global Atracurium Besylate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Atracurium Besylate Injection Sales Market Share by Type (2021-2032) Figure 13. Global Atracurium Besylate Injection Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Atracurium Besylate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Atracurium Besylate Injection Revenue Market Share by Type (2021-2032) Figure 16. Surgery Image Figure 17. Medical Examination Image Figure 18. Global Atracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 19. Global Atracurium Besylate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Atracurium Besylate Injection Sales Market Share by Application (2021-2032) Figure 21. Global Atracurium Besylate Injection Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 22. Global Atracurium Besylate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Atracurium Besylate Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 25. North America Atracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 26. U.S. Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 27. Canada Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 28. Mexico Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 29. Europe Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe Atracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 31. Germany Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 32. France Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 33. U.K. Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 34. Italy Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 35. Netherlands Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 36. Asia Pacific Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific Atracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 38. China Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 39. Japan Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 40. South Korea Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 41. Southeast Asia Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 42. India Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 43. Australia Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 44. South America, Middle East and Africa Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa Atracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 46. Brazil Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 47. South Africa Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 48. Saudi Arabia Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 49. Turkey Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 50. Argentina Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 51. UAE Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 52. Egypt Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 53. Chile Atracurium Besylate Injection Sales and Growth Rate (2021-2032) & (L) Figure 54. Global Atracurium Besylate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Atracurium Besylate Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 57. North America Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 59. Europe Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Atracurium Besylate Injection Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Atracurium Besylate Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5ml:12.5mg
  • 5ml:25mg
Applications
  • Surgery
  • Medical Examination
Companies covered
  • Qilu Pharma
  • Pfizer
  • Hengrui Medicine
  • GSK
  • SGPharma
  • Samarth Life Sciences
  • Lexicare Pharma
  • HBM Pharma
  • Gland Pharma
  • Flagship Biotech
  • Centurion Healthcare
  • American Remedies Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Atracurium Besylate Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Atracurium Besylate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Atracurium Besylate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Atracurium Besylate Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Atracurium Besylate Injection Market Dynamics
  1. 2.1 Atracurium Besylate Injection Industry Trends
  2. 2.2 Atracurium Besylate Injection Industry Drivers
  3. 2.3 Atracurium Besylate Injection Industry Opportunities and Challenges
  4. 2.4 Atracurium Besylate Injection Industry Restraints
3 Atracurium Besylate Injection Market by Manufacturers
  1. 3.1 Global Atracurium Besylate Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Atracurium Besylate Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Atracurium Besylate Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Atracurium Besylate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atracurium Besylate Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Atracurium Besylate Injection Manufacturers, Product Type & Application
  7. 3.7 Global Atracurium Besylate Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atracurium Besylate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atracurium Besylate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atracurium Besylate Injection Tier 1, Tier 2, and Tier 3
4 Atracurium Besylate Injection Market by Type
  1. 4.1 Atracurium Besylate Injection Type Introduction
  2. 4.1.1 2.5ml:12.5mg
  3. 4.1.2 5ml:25mg
  4. 4.2 Global Atracurium Besylate Injection Sales by Type
  5. 4.2.1 Global Atracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Atracurium Besylate Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Atracurium Besylate Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Atracurium Besylate Injection Revenue by Type
  9. 4.3.1 Global Atracurium Besylate Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Atracurium Besylate Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Atracurium Besylate Injection Revenue Market Share by Type (2021-2032)
5 Atracurium Besylate Injection Market by Application
  1. 5.1 Atracurium Besylate Injection Application Introduction
  2. 5.1.1 Surgery
  3. 5.1.2 Medical Examination
  4. 5.2 Global Atracurium Besylate Injection Sales by Application
  5. 5.2.1 Global Atracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Atracurium Besylate Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Atracurium Besylate Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Atracurium Besylate Injection Revenue by Application
  9. 5.3.1 Global Atracurium Besylate Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Atracurium Besylate Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Atracurium Besylate Injection Revenue Market Share by Application (2021-2032)
6 Global Atracurium Besylate Injection Sales by Region
  1. 6.1 Global Atracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atracurium Besylate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Atracurium Besylate Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Atracurium Besylate Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Atracurium Besylate Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Atracurium Besylate Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Atracurium Besylate Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Atracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Atracurium Besylate Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Atracurium Besylate Injection Revenue by Region
  1. 7.1 Global Atracurium Besylate Injection Revenue by Region
  2. 7.1.1 Global Atracurium Besylate Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Atracurium Besylate Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Atracurium Besylate Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Atracurium Besylate Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Atracurium Besylate Injection Revenue (2021-2032)
  8. 7.2.2 North America Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Atracurium Besylate Injection Revenue (2021-2032)
  11. 7.3.2 Europe Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Atracurium Besylate Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Atracurium Besylate Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Atracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Qilu Pharma
  2. 8.1.1 Qilu Pharma Company Information
  3. 8.1.2 Qilu Pharma Business Overview
  4. 8.1.3 Qilu Pharma Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Qilu Pharma Atracurium Besylate Injection Product Portfolio
  6. 8.1.5 Qilu Pharma Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Atracurium Besylate Injection Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Hengrui Medicine
  14. 8.3.1 Hengrui Medicine Company Information
  15. 8.3.2 Hengrui Medicine Business Overview
  16. 8.3.3 Hengrui Medicine Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hengrui Medicine Atracurium Besylate Injection Product Portfolio
  18. 8.3.5 Hengrui Medicine Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GSK Atracurium Besylate Injection Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 SGPharma
  26. 8.5.1 SGPharma Company Information
  27. 8.5.2 SGPharma Business Overview
  28. 8.5.3 SGPharma Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SGPharma Atracurium Besylate Injection Product Portfolio
  30. 8.5.5 SGPharma Recent Developments
  31. 8.6 Samarth Life Sciences
  32. 8.6.1 Samarth Life Sciences Company Information
  33. 8.6.2 Samarth Life Sciences Business Overview
  34. 8.6.3 Samarth Life Sciences Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Samarth Life Sciences Atracurium Besylate Injection Product Portfolio
  36. 8.6.5 Samarth Life Sciences Recent Developments
  37. 8.7 Lexicare Pharma
  38. 8.7.1 Lexicare Pharma Company Information
  39. 8.7.2 Lexicare Pharma Business Overview
  40. 8.7.3 Lexicare Pharma Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lexicare Pharma Atracurium Besylate Injection Product Portfolio
  42. 8.7.5 Lexicare Pharma Recent Developments
  43. 8.8 HBM Pharma
  44. 8.8.1 HBM Pharma Company Information
  45. 8.8.2 HBM Pharma Business Overview
  46. 8.8.3 HBM Pharma Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HBM Pharma Atracurium Besylate Injection Product Portfolio
  48. 8.8.5 HBM Pharma Recent Developments
  49. 8.9 Gland Pharma
  50. 8.9.1 Gland Pharma Company Information
  51. 8.9.2 Gland Pharma Business Overview
  52. 8.9.3 Gland Pharma Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gland Pharma Atracurium Besylate Injection Product Portfolio
  54. 8.9.5 Gland Pharma Recent Developments
  55. 8.10 Flagship Biotech
  56. 8.10.1 Flagship Biotech Company Information
  57. 8.10.2 Flagship Biotech Business Overview
  58. 8.10.3 Flagship Biotech Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Flagship Biotech Atracurium Besylate Injection Product Portfolio
  60. 8.10.5 Flagship Biotech Recent Developments
  61. 8.11 Centurion Healthcare
  62. 8.11.1 Centurion Healthcare Company Information
  63. 8.11.2 Centurion Healthcare Business Overview
  64. 8.11.3 Centurion Healthcare Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Centurion Healthcare Atracurium Besylate Injection Product Portfolio
  66. 8.11.5 Centurion Healthcare Recent Developments
  67. 8.12 American Remedies Healthcare
  68. 8.12.1 American Remedies Healthcare Company Information
  69. 8.12.2 American Remedies Healthcare Business Overview
  70. 8.12.3 American Remedies Healthcare Atracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 American Remedies Healthcare Atracurium Besylate Injection Product Portfolio
  72. 8.12.5 American Remedies Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atracurium Besylate Injection Value Chain Analysis
  2. 9.1.1 Atracurium Besylate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atracurium Besylate Injection Production Mode & Process
  6. 9.2 Atracurium Besylate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atracurium Besylate Injection Distributors
  9. 9.2.3 Atracurium Besylate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst